既往缺血性卒中显著改变新诊断癌症患者的卒中风险
该回顾性人群匹配队列研究纳入加拿大安大略省2010至2020年新诊断成人癌症患者65 525例,其中13 070例有缺血性卒中史,按1:4匹配无卒中史者。有既往缺血性卒中者癌症诊断后卒中发生率为261.3/10 000人年,无既往缺血性卒中者为75.3/10 000人年,校正后风险比aHR为2.68(95%CI 2.41-2.98)。
要点
- 新诊断癌症患者中,有既往缺血性卒中者癌症诊断后卒中风险约为无既往缺血性卒中者的2.68倍(aHR 2.68,95%CI 2.41-2.98)。
- 妇科癌症(aHR 3.84,95%CI 2.15-6.85)和肺癌(aHR 3.18,95%CI 2.52-4.02)亚组中既往缺血性卒中与后续卒中的关联最强。
- 既往卒中距癌症诊断时间越短风险越高,癌症诊断前1年内发生卒中者风险最高(aHR 3.68,95%CI 3.22-4.22)。
核心结论
- 在新诊断癌症患者中,有缺血性卒中史者癌症诊断后发生卒中的可能性约为无卒中史者的3倍,尤其当卒中发生在癌症诊断前1年内时。
研究设计与样本
- 回顾性人群匹配队列研究,纳入加拿大安大略省2010至2020年新诊断成人癌症患者(排除非黑色素瘤皮肤癌和原发性中枢神经系统肿瘤),共65 525例,其中13 070例有缺血性卒中史。
- 有既往缺血性卒中者按年龄、性别、癌症诊断年份、癌症分期和癌症部位以1:4匹配无卒中史者。
- 采用累积发生率函数曲线估计卒中发生率,计算以死亡为竞争事件的亚分布校正风险比(aHR)及95%CI,多变量分析校正基线特征不平衡。
主要发现
- 中位随访时间为743天(四分位距177-1729天)。
- 癌症诊断后卒中发生率在有既往缺血性卒中者为261.3/10 000人年,无既往缺血性卒中者为75.3/10 000人年。
- 有既往缺血性卒中者癌症诊断后卒中风险高于无既往缺血性卒中者(aHR 2.68,95%CI 2.41-2.98),且有既往缺血性卒中者心血管危险因素更普遍。
- 与无既往缺血性卒中者相比,妇科癌症亚组卒中风险最高(aHR 3.84,95%CI 2.15-6.85),肺癌亚组次之(aHR 3.18,95%CI 2.52-4.02)。
- 卒中风险与既往卒中间隔时间呈负相关,癌症诊断前1年内发生卒中者风险最高(aHR 3.68,95%CI 3.22-4.22)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous ischemic stroke (IS) is a risk factor for subsequent IS in the general population; it is unclear if this relationship remains true in patients with cancer. Our objective was to examine the association between previous IS and risk for future IS in individuals newly diagnosed with cancer. METHODS: We conducted a retrospective population-based matched cohort study of newly diagnosed adult cancer patients (excluding nonmelanoma skin cancers and primary central nervous system tumors) in Ontario, Canada from 2010 to 2020; those with prior IS were matched (1:4) by age, sex, year of cancer diagnosis, cancer stage, and cancer site to those without a history of stroke. Cumulative incidence function curves were created to estimate the incidence of IS. Subdistribution adjusted hazard ratios (aHRs) and 95% CIs were calculated, where death was treated as a competing event. Multivariable analysis was adjusted for imbalanced baseline characteristics. RESULTS: We examined 65 525 individuals with cancer, including 13 070 with a history of IS. The median follow-up duration was 743 days (interquartile range, 177-1729 days). The incidence of IS following cancer diagnosis was 261.3/10 000 person-years in the cohort with prior IS and 75.3/10 000 person-years in those without prior IS. Individuals with prior IS had an increased risk for IS after cancer diagnosis compared with those without a history (aHR, 2.68 [95% CI, 2.41-2.98]); they also had more prevalent cardiovascular risk factors. The highest risk for stroke compared with those without a history of IS was observed in the gynecologic cancer (aHR, 3.84 [95% CI, 2.15-6.85]) and lung cancer (aHR, 3.18 [95% CI, 2.52-4.02]) subgroups. The risk of IS was inversely correlated with lag time of previous stroke; those with IS 1 year before their cancer diagnosis had the highest risk (aHR, 3.68 [95% CI, 3.22-4.22]). CONCLUSIONS: Among individuals with newly diagnosed cancer, those with IS history were almost 3× more likely to experience a stroke after cancer diagnosis, especially if the prediagnosis stroke occurred within 1 year preceding cancer diagnosis.
引用
- Lun R, Cerasuolo JO, Carrier M, et al. Previous Ischemic Stroke Significantly Alters Stroke Risk in Newly Diagnosed Cancer Patients. Stroke. 2023. PMID: 37850360. doi:10.1161/STROKEAHA.123.042993
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。